LB Pharmaceuticals adopts amended charter and bylaws upon IPO closing on Sept 12, 2025

LB PHARMACEUTICALS INC

Filed amended and restated certificate of incorporation with Delaware Secretary of State.
Adopted amended and restated bylaws effective immediately prior to IPO closing.
Both documents previously approved by board and stockholders.
IPO closed on September 12, 2025; common stock trades on Nasdaq under LBRX.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.